Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Le

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Autophagy|June 18, 2025
Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitorsLucille Ferret, Jonathan G Pol, Allan Sauvat, et al.
Neurology and Therapy|December 23, 2022
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert ConsensusJerome De Sèze, Laurent Suchet, Claude Mekies, et al.
Journal of Clinical Medicine|November 26, 2022
The Spectrum of Still's Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 PatientsPierre-Antoine Neau, Thomas El-Jammal, Clément Javaux, et al.
Molecular Metabolism|January 29, 2019
The translational regulator FMRP controls lipid and glucose metabolism in mice and humansAntoine Leboucher, Didier F Pisani, Laura Martinez-Gili, et al.
Oncoimmunology|July 26, 2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesisJulie Le Naour, Léa Montégut, Yuhong Pan, et al.
Cell Reports. Medicine|March 18, 2026
Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutationYuhong Pan, Liwei Zhao, Jiani Liu, et al.
Microbiome|July 9, 2021
The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiotaPatricia Bermudez-Martin, Jérôme A J Becker, Nicolas Caramello, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
BMC Psychology|April 12, 2019
Pregnancy denial and early infant development: a case-control observational prospective studyJulie Auer, Coralie Barbe, Anne-Laure Sutter, et al.
The Lancet. Gastroenterology & Hepatology|April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Autophagy|June 18, 2025
Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitorsLucille Ferret, Jonathan G Pol, Allan Sauvat, et al.
Neurology and Therapy|December 23, 2022
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert ConsensusJerome De Sèze, Laurent Suchet, Claude Mekies, et al.
Journal of Clinical Medicine|November 26, 2022
The Spectrum of Still's Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 PatientsPierre-Antoine Neau, Thomas El-Jammal, Clément Javaux, et al.
Molecular Metabolism|January 29, 2019
The translational regulator FMRP controls lipid and glucose metabolism in mice and humansAntoine Leboucher, Didier F Pisani, Laura Martinez-Gili, et al.
Oncoimmunology|July 26, 2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesisJulie Le Naour, Léa Montégut, Yuhong Pan, et al.
Cell Reports. Medicine|March 18, 2026
Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutationYuhong Pan, Liwei Zhao, Jiani Liu, et al.
Microbiome|July 9, 2021
The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiotaPatricia Bermudez-Martin, Jérôme A J Becker, Nicolas Caramello, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
BMC Psychology|April 12, 2019
Pregnancy denial and early infant development: a case-control observational prospective studyJulie Auer, Coralie Barbe, Anne-Laure Sutter, et al.
The Lancet. Gastroenterology & Hepatology|April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
Pageof 15